| 11725007 |
Meta tyrosine derivatives as rho-kinase inhibitors |
Alessandro Accetta, Fabio Rancati, Christine Edwards, Gurdip Bhalay |
2023-08-15 |
|
| 11147812 |
Tyrosine analogues derivatives as Rho-kinase inhibitors |
Alessandro Accetta, Anna Maria Capelli, Fabio Rancati, Gurdip Bhalay, Arnaud Jean Francois Auguste Cheguillaume +1 more |
2021-10-19 |
|
| 10954236 |
Tyrosine amide derivatives as Rho-Kinase inhibitors |
Alessandro Accetta, Fabio Rancati, Anna Maria Capelli, David Edward Clark, Christine Edwards +2 more |
2021-03-23 |
|
| 10822342 |
Pyrazolopyrimidine derivatives as NIK inhibitors |
George Hynd, Calum Macleod, Samuel Edward Mann, Terry Aaron Panchal, John Gary Montana +1 more |
2020-11-03 |
$160,690,000 |
| 10584128 |
Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitors |
Alessandro Accetta, Fabio Rancati, Anna Maria Capelli, David Edward Clark, Christine Edwards +1 more |
2020-03-10 |
|
| 10501461 |
Tyrosine amide derivatives as Rho-kinase inhibitors |
Alessandro Accetta, Fabio Rancati, Anna Maria Capelli, David Edward Clark, Christine Edwards +2 more |
2019-12-10 |
|
| 10323045 |
Thienopyrimidine derivatives as NIK inhibitors |
George Hynd, Calum Macleod, Samuel Edward Mann, John Gary Montana, Stephen Price |
2019-06-18 |
$111,100,000 |
| 10221180 |
Pyrazolopyrimidine derivatives as NIK inhibitors |
George Hynd, Calum Macleod, Samuel Edward Mann, Terry Aaron Panchal, John Gary Montana +1 more |
2019-03-05 |
$272,142,000 |
| 10005773 |
1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors |
George Hynd, David Edward Clark, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann +3 more |
2018-06-26 |
$41,040,000 |
| 10005776 |
Compounds as NIK inhibitors |
George Hynd, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann, Stephen Price +1 more |
2018-06-26 |
$41,040,000 |
| 9981962 |
Pyrazole derivatives as NIK inhibitors |
George Hynd, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann, John Gary Montana +2 more |
2018-05-29 |
$56,746,000 |
| 9981963 |
3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors |
George Hynd, David Edward Clark, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann +3 more |
2018-05-29 |
$56,746,000 |
| 9643964 |
3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer |
George Hynd, Stephen Price, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann +2 more |
2017-05-09 |
$139,713,000 |
